UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Number of items: 290.

Article

(2013) Recent Advances in Clinical Cellular Immunotherapy. pp. 473-479. 10.1002/9781118520093.ch43.

Adams, A; Macmillan, D; Pizzey, A; Srai, K; (2013) STRATEGIES FOR THE SYNTHESIS OF HEPCIDIN AND ANALOGUES. AMERICAN JOURNAL OF HEMATOLOGY , 88 (5) E228-E229.

Agarwal, B; Gatt, A; Riddell, A; Wright, G; Chowdary, P; Jalan, R; Burroughs, AK; (2013) Hemostasis in patients with acute kidney injury secondary to acute liver failure. KIDNEY INTERNATIONAL , 84 (1) pp. 158-163. 10.1038/ki.2013.92.

Agarwal, B; Gatt, A; Riddell, A; Wright, G; Chowdary, P; Jalan, R; Burroughs, AK; (2013) Hemostasis in patients with acute kidney injury secondary to acute liver failure. Kidney International , 84 (1) pp. 158-163. 10.1038/ki.2013.92.

Ahmad, OF; Keane, MG; McCartney, S; Khwaja, A; Bloom, SL; (2013) Azathioprine-associated myelodysplastic syndrome in two patients with ulcerative colitis. Frontline Gastroenterol , 4 (3) pp. 205-209. 10.1136/flgastro-2012-100276.

Aikawa, E; Gardiner, C; Hutcheson, JD; Ochiya, T; Osteikoetxea, X; Pegtel, M; Piper, M; ... Buzas, EI; + view all (2013) International Society for Extracellular Vesicles: Second Annual Meeting, 17-20 April 2013, Boston, MA (ISEV 2013). J Extracell Vesicles , 2 23070-. 10.3402/jev.v2i0.23070.

Akarca, AU; Shende, VH; Ramsay, AD; Diss, T; Pane-Foix, M; Rizvi, H; Calaminici, MR; ... Marafioti, T; + view all (2013) BRAF V600E mutation-specific antibody, a sensitive diagnostic marker revealing minimal residual disease in hairy cell leukaemia. BRITISH JOURNAL OF HAEMATOLOGY , 162 (6) pp. 848-851. 10.1111/bjh.12429.

Alcada, J; Hockings, C; Taylor, A; McGuckin, S; Westwood, JP; Walker, D; Scully, M; (2013) Intensive care outcomes of patients with thrombotic thrombocytopenic purpura: a single centre study. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 11 p. 197.

Ali, A; Siddique, MK; Gale, RE; Shakoori, AR; (2013) Frequency of NPM1 Mutations in Pakistani Acute Myeloid Leukemia Patients. PAKISTAN JOURNAL OF ZOOLOGY , 45 (5) pp. 1429-1436.

Allen, C; Hills, RK; Lamb, K; Evans, C; Tinsley, S; Sellar, R; O'Brien, M; ... Gale, RE; + view all (2013) The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia. LEUKEMIA , 27 (9) pp. 1891-1901. 10.1038/leu.2013.186.

Arachchillage, DJ; Cohen, H; (2013) Use of New Oral Anticoagulants in Antiphospholipid Syndrome. CURRENT RHEUMATOLOGY REPORTS , 15 (6) 10.1007/s11926-013-0331-5.

Arachchillage, DJ; Cohen, H; (2013) Use of new oral anticoagulants in antiphospholipid syndrome. Current Rheumatology Reports , 15 (6) 10.1007/s11926-013-0331-5.

Arachchillage, JD; Efthymiou, M; Mackie, IJ; Lawrie, AS; Machin, SJ; Cohen, H; (2013) Investigation of resistance to exogenous activated protein C and activation of endogenous protein C in thrombotic patients with or without antiphospholipid syndrome. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 11 pp. 335-336.

Ball, J; Poles, D; Cohen, H; Bolton-Maggs, PHB; (2013) Delays in the transfusion of blood reported to the UK confidential haemovigilance scheme (Serious Hazards of Transfusion). BRITISH JOURNAL OF HAEMATOLOGY , 161 pp. 77-78.

Banaszynski, LA; Wen, D; Dewell, S; Whitcomb, SJ; Lin, M; Diaz, N; Elsaesser, SJ; ... Allis, CD; + view all (2013) Hira-Dependent Histone H3.3 Deposition Facilitates PRC2 Recruitment at Developmental Loci in ES Cells. CELL , 155 (1) pp. 107-120. 10.1016/j.cell.2013.08.061.

Becerra, E; de la Torre, I; Leandro, MJ; Heelas, EO; Westwood, J-P; Scully, M; Cambridge, G; (2013) B CELL ACTIVATING FACTOR RECEPTOR (BAFF-R) EXPRESSION AFTER RITUXIMAB: COMPARISON OF PATIENTS WITH RHEUMATOID ARTHRITIS AND THROMBOTIC THROMBOCYTOPENIC PURPURA. ANNALS OF THE RHEUMATIC DISEASES , 71 pp. 488-489. 10.1136/annrheumdis-2012-eular.3002.

Bhavsar, PJ; Infante, E; Khwaja, A; Ridley, AJ; (2013) Analysis of Rho GTPase expression in T-ALL identifies RhoU as a target for Notch involved in T-ALL cell migration. ONCOGENE , 32 (2) pp. 198-208. 10.1038/onc.2012.42.

Birchall, MA; Elliott, MJ; Lowdell, M; De Coppi, P; (2013) Stem-cell-based, tissue-engineered tracheal replacement in a child Reply. LANCET , 381 (9861) p. 113. 10.1016/S0140-6736(13)60044-6.

Bochtler, W; Maiers, M; Bakker, JNA; Baier, DM; Hofmann, JA; Pingel, J; Rist, H-G; ... Hurley, CK; + view all (2013) An update to the HLA Nomenclature Guidelines of the World Marrow Donor Association, 2012. BONE MARROW TRANSPLANTATION , 48 (11) pp. 1387-1388. 10.1038/bmt.2013.93.

Bolton-Maggs, PHB; Cohen, H; (2013) Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety. British Journal of Haematology , 163 (3) pp. 303-314. 10.1111/bjh.12547.

Bolton-Maggs, PHB; Cohen, H; (2013) Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety. BRITISH JOURNAL OF HAEMATOLOGY , 163 (3) pp. 303-314. 10.1111/bjh.12547.

Bolton-Maggs, PHB; Davies, T; Poles, D; Cohen, H; (2013) Errors in anti-D immunoglobulin administration: Retrospective analysis of 15 years of reports to the UK confidential haemovigilance scheme. BJOG: An International Journal of Obstetrics and Gynaecology , 120 (7) pp. 873-878. 10.1111/1471-0528.12175.

Bolton-Maggs, PHB; Davies, T; Poles, D; Cohen, H; (2013) Errors in anti-D immunoglobulin administration: retrospective analysis of 15years of reports to the UK confidential haemovigilance scheme. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY , 120 (7) pp. 873-878. 10.1111/1471-0528.12175.

Bolton-Maggs, PHB; Milkins, CE; Poles, D; Cohen, H; (2013) Adverse events related to blood transfusion: haemoglobinopathy patients are particularly at risk. BRITISH JOURNAL OF HAEMATOLOGY , 161 p. 3.

Bolton-Maggs, PHB; Poles, D; Cohen, H; (2013) Adverse incidents related to transfusion - haematology patients are at higher risk for missed specific requirements. BRITISH JOURNAL OF HAEMATOLOGY , 161 p. 78.

Bond, J; Hough, R; Moppett, J; Vora, A; Mitchell, C; Goulden, N; (2013) 'Stroke-like syndrome' caused by intrathecal methotrexate in patients treated during the UKALL 2003 trial. Leukemia , 27 (4) pp. 954-956. 10.1038/leu.2012.328.

Cappuzzo, V; Halliwell, JA; Ingrassia, F; Mistretta, S; Marsh, SGE; (2013) Characterisation of a new HLA-DRB1 allele: DRB1*03:85. TISSUE ANTIGENS , 82 (5) pp. 358-359. 10.1111/tan.12218.

Carpenter, J-P; Grasso, AE; Porter, JB; Shah, F; Dooley, J; Pennell, DJ; (2013) On myocardial siderosis and left ventricular dysfunction in hemochromatosis. JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE , 15 (ARTN 24) 10.1186/1532-429X-15-24.

Casanova, AAM; Tavarozzi, F; Wallis-Jones, S; McWhinnie, AJ; Madrigal, JA; Marsh, SGE; Latham, K; (2013) A rapid protocol for HLA-DRB1 and HLA-DPB1 PCR utilising AmpliTaq Gold (R) fast PCR Master Mix and the VeritiTM Fast Thermocycler for use in Sequence based typing (SBT). INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (5) p. 416.

Cleeter, MWJ; Chau, K-Y; Gluck, C; Mehta, A; Hughes, DA; Duchen, M; Wood, NW; ... Schapira, AH; + view all (2013) Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage. NEUROCHEMISTRY INTERNATIONAL , 62 (1) pp. 1-7. 10.1016/j.neuint.2012.10.010. Gold open access

Coats, CJ; Parisi, V; Ramos, M; Janagarajan, K; O'Mahony, C; Dawnay, A; Lachmann, RH; ... Elliott, PM; + view all (2013) Role of Serum N-Terminal Pro-Brain Natriuretic,Peptide Measurement in Diagnosis of Cardiac Involvement in Patients With Anderson-Fabry Disease. AMERICAN JOURNAL OF CARDIOLOGY , 111 (1) pp. 111-117. 10.1016/j.amjcard.2012.08.055.

Coats, CJ; Parisi, V; Ramos, M; Janagarajan, K; O'Mahony, C; Dawnay, A; Lachmann, RH; ... Elliott, PM; + view all (2013) Role of serum N-terminal pro-brain natriuretic peptide measurement in diagnosis of cardiac involvement in patients with anderson-fabry disease. American Journal of Cardiology , 111 (1) pp. 111-117. 10.1016/j.amjcard.2012.08.055.

Coelho, V; Krysov, S; Steele, A; Sanchez Hidalgo, M; Johnson, PW; Chana, PS; Packham, G; ... Forconi, F; + view all (2013) Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function. BLOOD , 122 (15) pp. 2664-2672. 10.1182/blood-2013-02-485425.

Cohen, H; Dore, C; Clawson, S; Hunt, BJ; Khamashta, M; Machin, SJ; Muirhead, N; (2013) RAPS: a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 11 p. 860.

Cunningham, D; Hawkes, EA; Jack, A; Qian, W; Smith, P; Mouncey, P; Pocock, C; ... Linch, D; + view all (2013) Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles. LANCET , 381 (9880) pp. 1817-1826. 10.1016/S0140-6736(13)60313-X.

Dignan, FL; Manwani, R; Potter, MN; Ethell, ME; Leonard, H; Brennan, J; Baker, J; (2013) A dedicated GvHD clinic may improve the quality of life for allogeneic stem cell transplant survivors. CLINICAL TRANSPLANTATION , 27 (1) E1-E2. 10.1111/ctr.12051.

Dignan, FL; Potter, MN; Ethell, ME; Taylor, M; Lewis, L; Brennan, J; McNamara, L; ... Shaw, BE; + view all (2013) High readmission rates are associated with a significant economic burden and poor outcome in patients with grade III/IV acute GvHD. CLINICAL TRANSPLANTATION , 27 (1) E56-E63. 10.1111/ctr.12065.

Duran, R; Mencacci, NE; Angeli, AV; Shoai, M; Deas, E; Houlden, H; Mehta, A; ... Foltynie, T; + view all (2013) The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease. Movement Disorders , 28 (2) 232 - 236. 10.1002/mds.25248. Green open access
file

Eapen, CE; Elias, JE; Mackie, I; Elias, E; (2013) Prognostic Significance of von Willebrand Factor in Cirrhosis: A Possible Mechanism. HEPATOLOGY , 58 (3) p. 1189. 10.1002/hep.26282.

Eberhard, H-P; Madbouly, AS; Gourraud, PA; Balere, ML; Feldmann, U; Gragert, L; Torres, HM; ... Mueller, CR; + view all (2013) Comparative validation of computer programs for haplotype frequency estimation from donor registry data. TISSUE ANTIGENS , 82 (2) pp. 93-105. 10.1111/tan.12160.

Efthymiou, M; Lawrie, AS; Mackie, IJ; Machin, SJ; Cohen, H; (2013) Thrombin generation testing to monitor warfarin anticoagulation in thrombotic antiphospholipid syndrome patients. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 11 p. 962.

Efthymiou, M; Mackie, IJ; Lawrie, AS; Machin, SJ; Cohen, H; (2013) The influence of anti-tissue factor pathway inhibitor (TFPI) antibodies on thrombin generation (TG) in thrombotic patients with and without antiphospholipid syndrome. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 11 p. 597.

Efthymiou, M; Mackie, IJ; Lawrie, AS; Machin, SJ; Cohen, H; (2013) The value of thrombin generation analysis in thrombotic antiphospholipid syndrome patients on warfarin. BRITISH JOURNAL OF HAEMATOLOGY , 161 pp. 38-39.

Elias, JE; Mackie, I; Eapen, CE; Chu, P; Shaw, JC; Elias, E; (2013) Porto-pulmonary hypertension exacerbated by platelet transfusion in a patient with ADAMTS13 deficiency. JOURNAL OF HEPATOLOGY , 58 (4) pp. 827-830. 10.1016/j.jhep.2012.11.003.

Elias, JE; Mackie, I; Eapen, CE; Chu, P; Shaw, JC; Elias, E; (2013) Porto-pulmonary hypertension exacerbated by platelet transfusion in a patient with ADAMTS13 deficiency. Journal of Hepatology , 58 (4) pp. 827-830. 10.1016/j.jhep.2012.11.003.

Emery, V; Zuckerman, M; Jackson, G; Aitken, C; Osman, H; Pagliuca, A; Potter, M; ... Clark, A; + view all (2013) Management of cytomegalovirus infection in haemopoietic stem cell transplantation. BRITISH JOURNAL OF HAEMATOLOGY , 162 (1) pp. 25-39. 10.1111/bjh.12363.

Escors, D; Liechtenstein, T; Perez-Janices, N; Schwarze, J; Dufait, I; Goyvaerts, C; Lanna, A; ... Breckpot, K; + view all (2013) Assessing T-cell responses in anticancer immunotherapy Dendritic cells or myeloid-derived suppressor cells? ONCOIMMUNOLOGY , 2 (10) 10.4161/onci.26148.

Etchin, J; Sanda, T; Mansour, MR; Kentsis, A; Montero, J; Le, BT; Christie, AL; ... Look, AT; + view all (2013) KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia. BRITISH JOURNAL OF HAEMATOLOGY , 161 (1) pp. 117-127. 10.1111/bjh.12231.

Etchin, J; Sun, Q; Kentsis, A; Farmer, A; Zhang, ZC; Sanda, T; Mansour, MR; ... Look, AT; + view all (2013) Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells. LEUKEMIA , 27 (1) pp. 66-74. 10.1038/leu.2012.219.

Evans, P; Porter, J; (2013) CONTRASTING SYNERGIES OF PLASMA NON-TRANSFERRIN BOUND IRON (NTBI) REMOVAL BETWEEN DIFFERENT CHELATOR COMBINATIONS DEPEND ON KINETIC DIFFERENCES OF IRON ACCESS BY SHUTTLE MOLECULES. AMERICAN JOURNAL OF HEMATOLOGY , 88 (5) E102-E102.

Evans, P; Shah, F; Sayani, F; Bansal, S; Garbowski, M; Weljie, A; Walter, P; ... Porter, J; + view all (2013) CONTRASTING RELATIONSHIPS OF SERUM NON-TRANSFERRIN BOUND IRON AND TRANSFERRIN SATURATION TO IRON OVERLOAD, INEFFECTIVE ERYTHROPOIESIS AND SERUM HEPCIDIN IN SICKLE CELL AND HALASSAEMIA DISORDERS. AMERICAN JOURNAL OF HEMATOLOGY , 88 (5) E152-E153.

Ferreira, YJ; Gardiner, C; Poli, M; Turner, K; Child, T; Sargent, IL; Theofanakis, C; ... others, ; + view all (2013) Session 66: Embryo quality: does it predict pregnancy? Human Reproduction , 28 (suppl 1) i104-i106.

Fielding, AK; Zakout, GA; (2013) Treatment of philadelphia chromosome-positive acute lymphoblastic leukemia. Current Hematologic Malignancy Reports , 8 (2) pp. 98-108. 10.1007/s11899-013-0155-4.

Fishman, JM; Lowdell, MW; Urbani, L; Ansari, T; Burns, AJ; Turmaine, M; North, J; ... De Coppi, P; + view all (2013) Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 110 (35) pp. 14360-14365. 10.1073/pnas.1213228110.

Foley, JH; Conway, EM; (2013) Gas6 gains entry into the coagulation cascade. Blood , 121 (4) pp. 570-571. 10.1182/blood-2012-11-468678.

Foley, JH; Kim, PY; Mutch, NJ; Gils, A; (2013) Insights into thrombin activatable fibrinolysis inhibitor function and regulation. Journal of Thrombosis and Haemostasis , 11 (suppleme) pp. 306-315. 10.1111/jth.12216.

Foley, JH; Orfeo, T; Undas, A; McLean, KC; Bernstein, IM; Rivard, G-E; Mann, KG; ... Brummel-Ziedins, KE; + view all (2013) From Principle to Practice: Bridging the Gap in Patient Profiling. PLoS ONE , 8 (1) , Article e54728 . 10.1371/journal.pone.0054728. Green open access
file

Franquesa, M; Hoogduijn, MJ; Reinders, ME; Eggenhofer, E; Engela, AU; Mensah, FK; Torras, J; ... Grinyó, JM; + view all (2013) Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting. Transplantation Journal , 96 (3) pp. 234-238. 10.1097/TP.0b013e318298f9fa.

Gallagher, CM; Asher, D; Mistry, H; Poles, D; Rowley, M; Cohen, H; Norfolk, D; (2013) Laboratory-related transfusion errors information technology is not a foolproof solution. BRITISH JOURNAL OF HAEMATOLOGY , 161 p. 1.

Gardiner, C; Ferreira, YJ; Dragovic, RA; Redman, CWG; Sargent, IL; (2013) Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis. J Extracell Vesicles , 2 10.3402/jev.v2i0.19671.

Gardiner, C; Hills, J; Machin, SJ; Cohen, H; (2013) Diagnosis of antiphospholipid syndrome in routine clinical practice. LUPUS , 22 (1) pp. 18-25. 10.1177/0961203312460722.

Gardiner, C; Hills, J; Machin, SJ; Cohen, H; (2013) Diagnosis of antiphospholipid syndrome in routine clinical practice. Lupus , 22 (1) 18 - 25. 10.1177/0961203312460722. Green open access
file

Gardiner, C; Kitchen, D; Machin, S; Mackie, I; (2013) Point-of-Care Testing in Hemostasis. pp. 147-156. 10.1002/9781118543467.ch14.

Gerlinger, M; Quezada, SA; Peggs, KS; Furness, AJS; Fisher, R; Marafioti, T; Shende, VH; ... Swanton, C; + view all (2013) Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas. JOURNAL OF PATHOLOGY , 231 (4) pp. 424-432. 10.1002/path.4284.

Goh, PA; Caxaria, S; Casper, C; Rosales, C; Warner, TT; Coffey, PJ; Nathwani, AC; (2013) A Systematic Evaluation of Integration Free Reprogramming Methods for Deriving Clinically Relevant Patient Specific Induced Pluripotent Stem (iPS) Cells. PLoS One , 8 (11) , Article e81622. 10.1371/journal.pone.0081622. Green open access
file

Goh, PA; Caxaria, S; Casper, C; Rosales, C; Warner, TT; Coffey, PJ; Nathwani, AC; (2013) A systematic evaluation of integration free reprogramming methods for deriving clinically relevant patient specific induced pluripotent stem (iPS) cells. PLoS ONE , 8 (11) 10.1371/journal.pone.0081622.

Gonzalez-Galarza, FF; Mack, SJ; Hollenbach, J; Fernandez-Vina, M; Setterholm, M; Kempenich, J; Marsh, SGE; ... Middleton, D; + view all (2013) 16th IHIW: Extending the number of resources and bioinformatics analysis for the investigation of HLA rare alleles. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (1) pp. 60-65. 10.1111/iji.12030.

Green, CL; Tawana, K; Hills, RK; Boedoer, C; Fitzgibbon, J; Inglott, S; Ancliff, P; ... Gale, RE; + view all (2013) GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations. BRITISH JOURNAL OF HAEMATOLOGY , 161 (5) pp. 701-705. 10.1111/bjh.12317.

Groeneveldt, L; Mein, G; Garrod, R; Jewell, AP; Van Someren, K; Stephens, R; D'Sa, SP; (2013) A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors. BMC Cancer , 13 , Article 31. 10.1186/1471-2407-13-31. Green open access
file

Hachani, R; Lowdell, M; Birchall, M; Thanh, NT; (2013) Tracking stem cells in tissue-engineered organs using magnetic nanoparticles. Nanoscale , 5 (23) pp. 11362-11373. 10.1039/c3nr03861k. Green open access
file

Halter, JP; van Walraven, SM; Worel, N; Bengtsson, M; Hagglund, H; de Faveri, GN; Shaw, BE; ... Confer, D; + view all (2013) Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: A consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). BONE MARROW TRANSPLANTATION , 48 (2) pp. 220-225. 10.1038/bmt.2012.119.

Hildebrandt, M; Apperley, J; Dickinson, AM; Edinger, M; Greinix, H; Hauser, A; Koehl, U; ... Lowdell, MW; + view all (2013) The Regulation of Advanced Therapy Medicinal Products (ATMPs) in Europe and the Role of Academia: Results of an FP7-funded Research Project. ONKOLOGIE , 36 p. 264.

Hogarth, V; Hughes, D; Orteu, CH; (2013) Pseudoacromegalic facial features in Fabry disease. CLINICAL AND EXPERIMENTAL DERMATOLOGY , 38 (2) pp. 137-139. 10.1111/j.1365-2230.2012.04420.x.

Holmberg, L; Wong, YNS; Tabár, L; Ringberg, A; Karlsson, P; Arnesson, L-G; Sandelin, K; ... Emdin, S; + view all (2013) Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised study. Br J Cancer , 108 (4) pp. 812-819. 10.1038/bjc.2013.26.

Hughes, DA; Deegan, PB; Milligan, A; Wright, N; Butler, LH; Jacobs, A; Mehta, AB; (2013) A randomised, double-blind, placebo-controlled, crossover study to assess the efficacy and safety of three dosing schedules of agalsidase alfa enzyme replacement therapy for Fabry disease. MOLECULAR GENETICS AND METABOLISM , 109 (3) pp. 269-275. 10.1016/j.ymgme.2013.04.015.

Hughes, DA; Pastores, GM; (2013) Haematological manifestations and complications of Gaucher disease. CURRENT OPINION IN HEMATOLOGY , 20 (1) pp. 41-47. 10.1097/MOH.0b013e32835a9148.

Jamal-Hanjani, M; Thanopoulou, E; Peggs, KS; Quezada, SA; Swanton, C; (2013) Tumour heterogeneity and immune-modulation. Curr Opin Pharmacol , 13 (4) 497 - 503. 10.1016/j.coph.2013.04.006. Green open access
file

Jenkinson, S; Koo, K; Mansour, MR; Goulden, N; Vora, A; Mitchell, C; Wade, R; ... Gale, RE; + view all (2013) Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial. LEUKEMIA , 27 (1) pp. 41-47. 10.1038/leu.2012.176.

Jenkinson, S; Koo, K; Mansour, MR; Goulden, N; Vora, A; Mitchell, C; Wade, R; ... Gale, RE; + view all (2013) Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial. Leukemia , 27 (1) pp. 41-47. 10.1038/leu.2012.176.

Jennings, I; Mackie, I; Kitchen, S; Kitchen, DP; Woods, TAL; Walker, ID; (2013) Variability in measurement of ADAMTS13: a UK NEQAS multicentre exercise for ADAMTS13 assays. BRITISH JOURNAL OF HAEMATOLOGY , 161 p. 35.

Karlsson, C; Baudet, A; Miharada, N; Soneji, S; Gupta, R; Magnusson, M; Enver, T; ... Larsson, J; + view all (2013) Identification of the chemokine CCL28 as a growth and survival factor for human hematopoietic stem and progenitor cells. BLOOD , 121 (19) pp. 3838-3842. 10.1182/blood-2013-02-481192.

Karlsson, G; Roerby, E; Pina, C; Soneji, S; Reckzeh, K; Miharada, K; Karlsson, C; ... Enver, T; + view all (2013) The Tetraspanin CD9 Affords High-Purity Capture of All Murine Hematopoietic Stem Cells. CELL REPORTS , 4 (4) pp. 642-648. 10.1016/j.celrep.2013.07.020.

Karlsson, G; Rörby, E; Pina, C; Soneji, S; Reckzeh, K; Miharada, K; Karlsson, C; ... Enver, T; + view all (2013) The tetraspanin CD9 affords high-purity capture of all murine hematopoietic stem cells. Cell Reports , 4 (4) pp. 642-648. 10.1016/j.celrep.2013.07.020.

Kepp, O; Martins, I; Menger, L; Michaud, M; Adjemian, S; Sukkurwala, AQ; Galluzzi, L; (2013) Quantification of cell cycle-arresting proteins. Methods Mol Biol , 965 pp. 121-142. 10.1007/978-1-62703-239-1_7.

Kepp, O; Menger, L; Vacchelli, E; Locher, C; Adjemian, S; Yamazaki, T; Martins, I; ... Zitvogel, L; + view all (2013) Crosstalk between ER stress and immunogenic cell death. Cytokine Growth Factor Rev , 24 (4) pp. 311-318. 10.1016/j.cytogfr.2013.05.001.

Knight, A; Arnouk, H; Britt, W; Gillespie, GY; Cloud, GA; Harkins, L; Su, Y; ... Lamb, LS; + view all (2013) CMV-Independent Lysis of Glioblastoma by Ex Vivo Expanded/Activated Vδ1+ γδ T Cells. PLoS One , 8 (8) , Article e68729. 10.1371/journal.pone.0068729. Green open access
file

Kong, X-F; Vogt, G; Itan, Y; Macura-Biegun, A; Szaflarska, A; Kowalczyk, D; Chapgier, A; ... Boisson-Dupuis, S; + view all (2013) Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease. HUMAN MOLECULAR GENETICS , 22 (4) pp. 769-781. 10.1093/hmg/dds484.

Kuter, DJ; Mehta, A; Hollak, CEM; Giraldo, P; Hughes, D; Belmatoug, N; Brand, M; ... Zimran, A; + view all (2013) Miglustat therapy in type 1 Gaucher disease: Clinical and safety outcomes in a multicenter retrospective cohort study. BLOOD CELLS MOLECULES AND DISEASES , 51 (2) pp. 116-124. 10.1016/j.bcmd.2013.04.005.

Kwok, J; Lau, RW; Halliwell, J; Marsh, SGE; (2013) Identification of a novel HLA-DRB1*11:129 allele in a Chinese individual by sequence-based typing. TISSUE ANTIGENS , 81 (4) 237-U104. 10.1111/tan.12069.

Lal, A; Porter, J; Sweeters, N; Ng, V; Evans, P; Neumayr, L; Kurio, G; ... Vichinsky, E; + view all (2013) Combined chelation therapy with deferasirox and deferoxamine in thalassemia. BLOOD CELLS MOLECULES AND DISEASES , 50 (2) pp. 99-104. 10.1016/j.bcmd.2012.10.006.

Lal, A; Porter, J; Sweeters, N; Ng, V; Evans, P; Neumayr, L; Kurio, G; ... Vichinsky, E; + view all (2013) Combined chelation therapy with deferasirox and deferoxamine in thalassemia. Blood Cells, Molecules, and Diseases , 50 (2) pp. 99-104. 10.1016/j.bcmd.2012.10.006.

Laufer, J; Jathoul, A; Pule, M; Beard, P; (2013) In vitro characterization of genetically expressed absorbing proteins using photoacoustic spectroscopy. BIOMEDICAL OPTICS EXPRESS , 4 (11) pp. 2477-2490. 10.1364/BOE.4.002477.

Lawrie, AS; Kitchen, S; Efthymiou, M; Mackie, IJ; Machin, SJ; (2013) Determination of APTT factor sensitivity - the misguiding guideline. Int J Lab Hematol , 35 (6) pp. 652-657. 10.1111/ijlh.12109. Green open access
file

Lawrie, AS; Kobayashi, K; Lane, P; Mackie, IJ; Machin, SJ; (2013) Automation of light transmission platelet aggregation. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 11 p. 1142.

Lawrie, AS; Stufano, F; Canciani, MT; Mackie, IJ; Machin, SJ; Peyvandi, F; (2013) A comparative evaluation of a new automated assay for von Willebrand factor activity. HAEMOPHILIA , 19 (2) pp. 338-342. 10.1111/hae.12064.

Lawrie, AS; Stufano, F; Canciani, MT; Mackie, IJ; Machin, SJ; Peyvandi, F; (2013) A comparative evaluation of a new automated assay for von Willebrand factor activity. Haemophilia , 19 (2) pp. 338-342. 10.1111/hae.12064.

Lee, JW; Yoon, S-S; Shen, ZX; Ganser, A; Hsu, H-C; El-Ali, A; Habr, D; ... Porter, JB; + view all (2013) Hematologic responses in patients with aplastic anemia treated with deferasirox: a post hoc analysis from the EPIC study. HAEMATOLOGICA , 98 (7) pp. 1045-1048. 10.3324/haematol.2012.077669.

Liechtenstein, T; Perez-Janices, N; Bricogne, C; Lanna, A; Dufait, I; Goyvaerts, C; Laranga, R; ... Escors, D; + view all (2013) Immune modulation by genetic modification of dendritic cells with lentiviral vectors. VIRUS RESEARCH , 176 (1-2) pp. 1-15. 10.1016/j.virusres.2013.05.007.

Liu, D; Ferrer, IR; Konomos, M; Ford, ML; (2013) Inhibition of CD8+ T cell-derived CD40 signals is necessary but not sufficient for Foxp3+ induced regulatory T cell generation in vivo. J Immunol , 191 (4) pp. 1957-1964. 10.4049/jimmunol.1300267.

Lown, RN; Shaw, BE; (2013) Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision. Bone Marrow Transplant , 48 (2) pp. 210-219. 10.1038/bmt.2012.54.

Lown, RN; Tulpule, S; Russell, NH; Craddock, CF; Roest, R; Madrigal, JA; Shaw, BE; (2013) Subsequent donation requests among 2472 unrelated hematopoietic progenitor cell donors are associated with bone marrow harvest. HAEMATOLOGICA , 98 (12) pp. 1956-1963. 10.3324/haematol.2013.088971.

Lowry, L; Smith, P; Cunningham, D; Linch, DC; (2013) Factors affecting survival in patients aged 60 and over with diffuse large B cell lymphoma failing first-line therapy. JOURNAL OF GERIATRIC ONCOLOGY , 4 (2) pp. 134-140. 10.1016/j.jgo.2012.12.001.

Ma, Y; Adjemian, S; Mattarollo, SR; Yamazaki, T; Aymeric, L; Yang, H; Portela Catani, JP; ... Kroemer, G; + view all (2013) Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity , 38 (4) pp. 729-741. 10.1016/j.immuni.2013.03.003.

Mack, SJ; Cano, P; Hollenbach, JA; He, J; Hurley, CK; Middleton, D; Moraes, ME; ... Fernandez-Vina, M; + view all (2013) Common and well-documented HLA alleles: 2012 update to the CWD catalogue. TISSUE ANTIGENS , 81 (4) pp. 194-203. 10.1111/tan.12093.

Mackie, I; Cooper, P; Lawrie, A; Kitchen, S; Gray, E; Laffan, M; (2013) Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY , 35 (1) pp. 1-13. 10.1111/ijlh.12004.

Mackie, I; Cooper, P; Lawrie, A; Kitchen, S; Gray, E; Laffan, M; (2013) Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. International Journal of Laboratory Hematology , 35 (1) pp. 1-13. 10.1111/ijlh.12004.

Mackie, I; Langley, K; Chitolie, A; Liesner, R; Scully, M; Machin, S; Peyvandi, F; (2013) Discrepancies between ADAMTS13 activity assays in patients with thrombotic microangiopathies. THROMBOSIS AND HAEMOSTASIS , 109 (3) pp. 488-496. 10.1160/TH12-08-0565.

Maharaj, L; Marson, CM; Middleton, BJ; Rioja, AS; Perry, J; Oakervee, H; Cavenagh, J; ... Popat, R; + view all (2013) The histone deacetylase inhibitor UCL67022 has potent activity in multiple myeloma and non-Hodgkin lymphoma pre-clinical models. BRITISH JOURNAL OF HAEMATOLOGY , 163 (1) pp. 135-139. 10.1111/bjh.12456.

Maharaj, L; Marson, CM; Middleton, BJ; Rioja, AS; Perry, J; Oakervee, H; Cavenagh, J; ... Popat, R; + view all (2013) The histone deacetylase inhibitor UCL67022 has potent activity in multiple myeloma and non-Hodgkin lymphoma pre-clinical models. British Journal of Haematology , 163 (1) pp. 135-139. 10.1111/bjh.12456.

Maiers, M; Gragert, L; Madbouly, A; Steiner, D; Marsh, SG; Gourraud, PA; Oudshoorn, M; ... Eberhard, HP; + view all (2013) 16(th) IHIW: global analysis of registry HLA haplotypes from 20 million individuals: report from the IHIW Registry Diversity Group. International Journal of Immunogenetics , 40 (1) 66 -71. 10.1111/iji.12031.

Mallett, SV; Chowdary, P; Burroughs, AK; (2013) Clinical utility of viscoelastic tests of coagulation in patients with liver disease. LIVER INTERNATIONAL , 33 (7) pp. 961-974. 10.1111/liv.12158.

Mansour, MR; Sanda, T; Lawton, LN; Li, X; Kreslavsky, T; Novina, CD; Brand, M; ... Look, AT; + view all (2013) The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia. JOURNAL OF EXPERIMENTAL MEDICINE , 210 (8) pp. 1545-1557. 10.1084/jem.20122516.

Marks, DI; Moorman, AV; Chilton, L; Paietta, E; Enshaie, A; DeWald, G; Harrison, CJ; ... Lazarus, HM; + view all (2013) The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial. HAEMATOLOGICA , 98 (6) pp. 945-952. 10.3324/haematol.2012.081877. Gold open access

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update April 2013. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (5) pp. 424-428. 10.1111/iji.12083.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update April 2013. TISSUE ANTIGENS , 82 (3) pp. 219-223. 10.1111/tan.12180.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update August 2012. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (2) pp. 161-164. 10.1111/iji.12013.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update August 2013. TISSUE ANTIGENS , 82 (6) pp. 452-457. 10.1111/tan.12236.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update August 2013. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (6) pp. 533-537. 10.1111/iji.12099.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update December 2012. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (3) pp. 256-259. 10.1111/iji.12050.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update December 2012. TISSUE ANTIGENS , 81 (4) pp. 253-257. 10.1111/tan.12077.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update December 2012. Human Immunology , 74 (5) pp. 689-692. 10.1016/j.humimm.2013.01.018.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update February 2013. TISSUE ANTIGENS , 81 (6) pp. 474-479. 10.1111/tan.12131.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update February 2013. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (4) pp. 338-342. 10.1111/iji.12062.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update February 2013. Compiled by Steven G.E. Marsh for the WHO Nomenclature Committee for Factors of the HLA System. Human Immunology , 74 (7) pp. 890-893. 10.1016/j.humimm.2013.04.005.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update January 2013. TISSUE ANTIGENS , 81 (6) pp. 471-473. 10.1111/tan.12130.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update January 2013. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (4) pp. 335-337. 10.1111/iji.12061.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update January 2013. Compiled by Steven G.E. Marsh for the WHO Nomenclature Committee for Factors of the HLA System. Human Immunology , 74 (7) pp. 888-889. 10.1016/j.humimm.2013.04.004.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update July 2012. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (2) pp. 156-160. 10.1111/iji.12012.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update July 2013. TISSUE ANTIGENS , 82 (6) pp. 447-451. 10.1111/tan.12235.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update July 2013. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (6) pp. 528-532. 10.1111/iji.12100.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update June 2013. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (5) pp. 434-437. 10.1111/iji.12079.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update June 2013. TISSUE ANTIGENS , 82 (3) pp. 229-233. 10.1111/tan.12182.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update March 2013. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (4) pp. 343-347. 10.1111/iji.12063.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update March 2013. TISSUE ANTIGENS , 81 (6) pp. 480-484. 10.1111/tan.12132.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update March 2013. Compiled by Steven G.E. Marsh for the WHO Nomenclature Committee for Factors of the HLA System. Human Immunology , 74 (7) pp. 894-897. 10.1016/j.humimm.2013.04.006.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update May 2013. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (5) pp. 429-433. 10.1111/iji.12078.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update May 2013. TISSUE ANTIGENS , 82 (3) pp. 224-228. 10.1111/tan.12181.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update November 2012. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (3) pp. 252-255. 10.1111/iji.12049.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update November 2012. Human Immunology , 74 (5) pp. 686-688. 10.1016/j.humimm.2013.01.017.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update November 2012. TISSUE ANTIGENS , 81 (4) pp. 249-252. 10.1111/tan.12076.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update October 2012. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (3) pp. 246-251. 10.1111/iji.12048.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update October 2012. Human Immunology , 74 (5) pp. 681-685. 10.1016/j.humimm.2013.01.016.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update October 2012. TISSUE ANTIGENS , 81 (4) pp. 242-248. 10.1111/tan.12075.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update September 2012. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (2) pp. 165-170. 10.1111/iji.12023.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update September 2013. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (6) pp. 538-541. 10.1111/iji.12101.

Marsh, SGE; (2013) Nomenclature for factors of the HLA system, update September 2013. TISSUE ANTIGENS , 82 (6) pp. 458-461. 10.1111/tan.12237.

Martins, I; Kepp, O; Menger, L; Michaud, M; Adjemian, S; Sukkurwala, AQ; Vacchelli, E; ... Kroemer, G; + view all (2013) Fluorescent biosensors for the detection of HMGB1 release. Methods Mol Biol , 1004 pp. 43-56. 10.1007/978-1-62703-383-1_4.

Mattar, CN; Rosales, C; Fragata, R; McIntosh, J; Johana, N; Waddington, SN; Kaeppel, C; ... Chan, JKY; + view all (2013) A robust preclinical model for fetal gene therapy: strategies targeting the liver for molecular correction of congenital single gene defects at early and late gestation. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY , 120 p. 5.

Mavrelos, D; Cohen, H; Pateman, K; Hoo, W; Foo, X; Jurkovic, D; (2013) Diagnosis of uterine vein thrombosis on transvaginal ultrasound. Ultrasound in Obstetrics and Gynecology , 42 (4) pp. 480-483. 10.1002/uog.12520.

Mc Guckin, S; Westwood, J; Lambert, J; Scully, M; (2013) Efficacy of pegylated interferon in myelo-proliferative disorders. BRITISH JOURNAL OF HAEMATOLOGY , 161 pp. 64-65.

McIntosh, J; Lenting, PJ; Rosales, C; Lee, D; Rabbanian, S; Raj, D; Patel, N; ... Nathwani, AC; + view all (2013) Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant. BLOOD , 121 (17) pp. 3335-3344. 10.1182/blood-2012-10-462200.

McNeill, A; Roberti, G; Lascaratos, G; Hughes, D; Mehta, A; Garway-Heath, DF; Schapira, AH; (2013) Retinal thinning in Gaucher disease patients and carriers: results of a pilot study. Molecular Genetics and Metabolism , 109 (2) 221 - 223. 10.1016/j.ymgme.2013.04.001. Green open access
file

Mead, AJ; Chowdhury, O; Pecquet, C; Dusa, A; Woll, P; Atkinson, D; Burns, A; ... Jacobsen, SEW; + view all (2013) Impact of isolated germline JAK2V617I mutation on human hematopoiesis. BLOOD , 121 (20) pp. 4156-4165. 10.1182/blood-2012-05-430926.

Medd, PG; Peniket, AJ; Littlewood, TJ; Pearce, R; Perry, J; Kirkland, KE; Shaw, BE; ... Cook, G; + view all (2013) Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: A British Society of Blood and Marrow Transplantation study. Bone Marrow Transplantation , 48 (7) pp. 982-987. 10.1038/bmt.2012.261.

Medd, PG; Peniket, AJ; Littlewood, TJ; Pearce, R; Perry, J; Kirkland, KE; Shaw, BE; ... Cook, G; + view all (2013) Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study. BONE MARROW TRANSPLANTATION , 48 (7) pp. 982-987. 10.1038/bmt.2012.261.

Medd, PG; Peniket, AJ; Littlewood, TJ; Pearce, R; Perry, J; Kirkland, KE; Shaw, BE; ... Cook, G; + view all (2013) Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study. Bone Marrow Transplant , 48 (10) 1368-. 10.1038/bmt.2013.119.

Menger, L; Vacchelli, E; Kepp, O; Eggermont, A; Tartour, E; Zitvogel, L; Kroemer, G; (2013) Trial watch: Cardiac glycosides and cancer therapy. Oncoimmunology , 2 (2) , Article e23082. 10.4161/onci.23082.

Mepani, K; Wallis-Jones, S; McWhinnie, AJ; Madrigal, JA; Latham, K; Marsh, SGE; (2013) Identification of a Novel Allele, HLA-DRB1*11:98 using group specific amplification. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (5) p. 412.

Middleton, D; Marsh, SGE; (2013) 16th International HLA and Immunogenetics Workshop (IHIW) Introduction. Int J Immunogenet , 40 (1) 1-. 10.1111/iji.12034.

Milius, RP; Mack, SJ; Hollenbach, JA; Pollack, J; Heuer, ML; Gragert, L; Spellman, S; ... Maiers, M; + view all (2013) Genotype List String: a grammar for describing HLA and KIR genotyping results in a text string. Tissue Antigens , 82 (2) pp. 106-112. 10.1111/tan.12150. Green open access
file

Montoto, S; Corradini, P; Dreyling, M; Ghielmini, M; Kimby, E; Lopez-Guillermo, A; Mackinnon, S; ... Dreger, P; + view all (2013) Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party. HAEMATOLOGICA , 98 (7) pp. 1014-1021. 10.3324/haematol.2013.084723. Gold open access

Morris, CR; Kim, H-Y; Wood, J; Porter, JB; Klings, ES; Trachtenberg, FL; Sweeters, N; ... Vichinsky, EP; + view all (2013) Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension. HAEMATOLOGICA , 98 (9) pp. 1359-1367. 10.3324/haematol.2012.082065.

Murphy, M; Porter, J; Yusuf, H; Ntouva, A; Newton, T; Kolliakou, A; Crawley, H; ... Watt, RG; + view all (2013) Considerations and lessons learned from designing a motivational interviewing obesity intervention for young people attending dental practices: A study protocol paper. CONTEMPORARY CLINICAL TRIALS , 36 (1) pp. 126-134. 10.1016/j.cct.2013.06.016.

Musallam, KM; Angastiniotis, M; Eleftheriou, A; Porter, JB; (2013) Cross-Talk between Available Guidelines for the Management of Patients with Beta-Thalassemia Major. ACTA HAEMATOLOGICA , 130 (2) pp. 64-73. 10.1159/000345734.

Musallam, KM; Porter, JB; Sfeir, PM; Tamim, HM; Richards, T; Lotta, LA; Peyvandi, F; (2013) Raised haematocrit concentration and the risk of death and vascular complications after major surgery. BRITISH JOURNAL OF SURGERY , 100 (8) pp. 1030-1036. 10.1002/bjs.9176.

Nacheva, EP; Grace, CD; Brazma, D; Gancheva, K; Howard-Reeves, J; Rai, L; Gale, RE; ... Kottaridis, PD; + view all (2013) Does BCR/ABL1 positive Acute Myeloid Leukaemia Exist? BRITISH JOURNAL OF HAEMATOLOGY , 161 (4) pp. 541-550. 10.1111/bjh.12301.

Nacheva, EP; Grace, CD; Gancheva, K; Rai, L; Brazma, D; Howard-Reeves, J; Kottaridis, PD; ... Russell, N; + view all (2013) Does BCR/ABL1 positive Acute Myeloid Leukaemia Exist? British Journal of Haematology , 161 (4) 541 - 550. 10.1111/bjh.12301. Green open access
file

Partington, L; Mordan, NJ; Mason, C; Knowles, JC; Kim, H-W; Lowdell, MW; Birchall, MA; (2013) Biochemical changes caused by decellularization may compromise mechanical integrity of tracheal scaffolds. ACTA BIOMATERIALIA , 9 (2) pp. 5251-5261. 10.1016/j.actbio.2012.10.004.

Pascual-García, M; Rué, L; León, T; Julve, J; Carbó, JM; Matalonga, J; Auer, H; ... Valledor, AF; + view all (2013) Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expression. J Immunol , 190 (12) pp. 6520-6532. 10.4049/jimmunol.1201393.

Pearce, KF; Hildebrandt, MO; Scheding, S; Koehl, U; Mischak-Weissinger, E; Hauser, A; Edinger, M; ... Dickinson, AM; + view all (2013) THE REGULATION OF ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE AND THE ROLE OF ACADEMIA. CYTOTHERAPY , 15 (4) S51-S52. 10.1016/j.jcyt.2013.01.200.

Pedroza-Pacheco, I; Madrigal, A; Saudemont, A; (2013) Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy. CELLULAR & MOLECULAR IMMUNOLOGY , 10 (3) pp. 222-229. 10.1038/cmi.2013.2.

Peggs, KS; (2013) Attack of the T-cell clones. BLOOD , 122 (11) pp. 1847-1848. 10.1182/blood-2013-07-511022.

Pidala, J; Wang, T; Haagenson, M; Spellman, SR; Askar, M; Battiwalla, M; Baxter-Lowe, LA; ... Anasetti, C; + view all (2013) Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality. BLOOD , 122 (22) pp. 3651-3658. 10.1182/blood-2013-05-501510.

Pina, NFG; Tavarozzi, F; Grewal, R; Wallis-Jones, S; Madrigal, JA; Marsh, SGE; Latham, K; (2013) Resolution of sequence-based typing (SBT) ambiguities using AmbisolvTM primer mixes. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 40 (5) pp. 415-416.

Popat, R; Maharaj, L; Oakervee, H; Cavenagh, J; Joel, S; (2013) Schedule dependent cytotoxicity of bortezomib and melphalan in multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY , 160 (1) pp. 111-114. 10.1111/bjh.12089.

Popat, R; Plesner, T; Davies, F; Cook, G; Cook, M; Elliott, P; Jacobson, E; ... Cavenagh, J; + view all (2013) A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY , 160 (5) pp. 714-717. 10.1111/bjh.12154.

Popat, R; Plesner, T; Davies, F; Cook, G; Cook, M; Elliott, P; Jacobson, E; ... Cavenagh, J; + view all (2013) A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma. British Journal of Haematology , 160 (5) pp. 714-717. 10.1111/bjh.12154.

Porter, J; Garbowski, M; (2013) Consequences and management of iron overload in sickle cell disease. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM pp. 447-456. 10.1182/asheducation-2013.1.447.

Porter, J; Walter, P; Neumayr, L; Evans, P; Weyhmiller, M; Harmatz, P; Wood, J; ... Vichinsky, E; + view all (2013) BIO-MARKERS OF IRON TRAFFICKING AND DISTRIBUTION IN TRANSFUSIONAL OVERLOAD: INSIGHTS FROM COMPARING DIOND BLACKFAN ANEMIA WITH SICKLE CELL DISEASE AND THALASSEMIA (MCSIO PILOT STUDY). AMERICAN JOURNAL OF HEMATOLOGY , 88 (5) E46-E47.

Porter, JB; Elalfy, MS; Taher, AT; Aydinok, Y; Chan, LL; Lee, S-H; Sutcharitchan, P; ... El-Beshlawy, A; + view all (2013) Efficacy and safety of deferasirox at low and high iron burdens: results from the EPIC magnetic resonance imaging substudy. ANNALS OF HEMATOLOGY , 92 (2) pp. 211-219. 10.1007/s00277-012-1588-x.

Porter, JB; Elalfy, MS; Taher, AT; Aydinok, Y; Chan, LL; Lee, SH; Sutcharitchan, P; ... El-Beshlawy, A; + view all (2013) Efficacy and safety of deferasirox at low and high iron burdens: Results from the EPIC magnetic resonance imaging substudy. Annals of Hematology , 92 (2) pp. 211-219. 10.1007/s00277-012-1588-x.

Porter, JB; Wood, J; Olivieri, N; Vichinsky, EP; Taher, A; Neufeld, E; Giardina, P; ... Trachtenberg, F; + view all (2013) Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone. Journal of Cardiovascular Magnetic Resonance , 15 , Article 38. 10.1186/1532-429X-15-38. Green open access
file

Pulsipher, MA; Chitphakdithai, P; Logan, BR; Shaw, BE; Wingard, JR; Lazarus, HM; Waller, EK; ... Confer, DL; + view all (2013) Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program. Blood , 121 (1) pp. 197-206. 10.1182/blood-2012-03-417667.

Quezada, SA; Peggs, KS; (2013) Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer. British Journal of Cancer , 108 (8) 1560 -1565. 10.1038/bjc.2013.117. Green open access
file

Rallapalli, PM; Kemball-Cook, G; Tuddenham, EG; Gomez, K; Perkins, SJ; (2013) An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 11 (7) pp. 1329-1340. 10.1111/jth.12276.

Reading, JL; Sabbah, S; Busch, S; Tree, TI; (2013) Mesenchymal stromal cells as a means of controlling pathological T-cell responses in allogeneic islet transplantation. Current Opinion in Organ Transplantation , 18 (1) pp. 59-64. 10.1097/MOT.0b013e32835c2adf.

Reed, M; Baker, RJ; Mehta, AB; Hughes, DA; (2013) Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease. BLOOD CELLS MOLECULES AND DISEASES , 51 (3) pp. 185-194. 10.1016/j.bcmd.2013.04.006.

Ricciardelli, I; Brewin, J; Lugthart, G; Albon, SJ; Pule, M; Amrolia, PJ; (2013) Rapid Generation of EBV-Specific Cytotoxic T Lymphocytes Resistant to Calcineurin Inhibitors for Adoptive Immunotherapy. Am J Transplant , 13 (12) 3244 - 3252. 10.1111/ajt.12475. Green open access
file

Richardson, SE; Khan, I; Rawstron, A; Sudak, J; Edwards, N; Verfuerth, S; Fielding, AK; ... Chakraverty, R; + view all (2013) Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia. BRITISH JOURNAL OF HAEMATOLOGY , 160 (5) pp. 640-648. 10.1111/bjh.12197.

Richardson, SE; Khan, I; Rawstron, A; Sudak, J; Edwards, N; Verfuerth, S; Fielding, AK; ... Chakraverty, R; + view all (2013) Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia. British Journal of Haematology , 160 (5) pp. 640-648. 10.1111/bjh.12197.

Roberts, TC; Godfrey, C; McClorey, G; Vader, P; Briggs, D; Gardiner, C; Aoki, Y; ... Wood, MJA; + view all (2013) Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover. NUCLEIC ACIDS RESEARCH , 41 (20) pp. 9500-9513. 10.1093/nar/gkt724.

Roberts, TC; Godfrey, C; McClorey, G; Vader, P; Briggs, D; Gardiner, C; Aoki, Y; ... Wood, MJA; + view all (2013) Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover. Nucleic acids research gkt724-gkt724.

Robinson, J; Halliwell, JA; McWilliam, H; Lopez, R; Marsh, SG; (2013) IPD—the Immuno Polymorphism Database. Nucleic Acids Research , 41 D1234 - D1240. 10.1093/nar/gks1140. Green open access
file

Robinson, J; Halliwell, JA; McWilliam, H; Lopez, R; Parham, P; Marsh, SG; (2013) The IMGT/HLA database. Nucleic Acids Res , 41 (D1) D1222 -D1227. 10.1093/nar/gks949. Green open access
file

Sabry, M; Lowdell, MW; (2013) Tumor-Primed NK Cells: Waiting for the Green Light. Front Immunol , 4 , Article 408. 10.3389/fimmu.2013.00408. Green open access
file

Sado, DM; White, SK; Piechnik, SK; Banypersad, SM; Treibel, T; Captur, G; Fontana, M; ... Moon, JC; + view all (2013) Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping. CIRCULATION-CARDIOVASCULAR IMAGING , 6 (3) pp. 392-398. 10.1161/CIRCIMAGING.112.000070.

Samuel, ER; Newton, K; MacKinnon, S; Lowdell, MW; (2013) Successful isolation and expansion of CMV-reactive T cells from G-CSF mobilized donors that retain a strong cytotoxic effector function. British Journal of Haematology , 160 (1) pp. 87-100. 10.1111/bjh.12082.

Samuel, ER; Newton, K; Mackinnon, S; Lowdell, MW; (2013) Successful isolation and expansion of CMV-reactive T cells from G-CSF mobilized donors that retain a strong cytotoxic effector function. BRITISH JOURNAL OF HAEMATOLOGY , 160 (1) pp. 87-100. 10.1111/bjh.12082.

Sekhar, M; McVinnie, K; Burroughs, AK; (2013) Splanchnic vein thrombosis in myeloproliferative neoplasms. BRITISH JOURNAL OF HAEMATOLOGY , 162 (6) pp. 730-747. 10.1111/bjh.12461.

Sekhar, M; McVinnie, K; Burroughs, AK; (2013) Splanchnic vein thrombosis in myeloproliferative neoplasms. Br J Haematol , 162 (6) pp. 730-747. 10.1111/bjh.12461.

Shaw, BE; Chapman, J; Fechter, M; Foeken, L; Greinix, H; Hwang, W; Phillips-Johnson, L; ... Szer, J; + view all (2013) Towards a global system of vigilance and surveillance in unrelated donors of haematopoietic progenitor cells for transplantation. BONE MARROW TRANSPLANTATION , 48 (12) pp. 1506-1509. 10.1038/bmt.2013.104.

Shaw, BE; Nolan, A; (2013) Allogeneic Transplantation: When is a Mismatch Better than a Match? BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , 19 (1) pp. 1-2. 10.1016/j.bbmt.2012.11.004.

Shaw, BE; Robinson, J; Fleischhauer, K; Madrigal, JA; Marsh, SGE; (2013) Translating the HLA-DPB1 T-cell epitope-matching algorithm into clinical practice. BONE MARROW TRANSPLANTATION , 48 (12) pp. 1510-1512. 10.1038/bmt.2013.91.

Shepherd, C; Banerjee, L; Cheung, CW; Mansour, MR; Jenkinson, S; Gale, RE; Khwaja, A; (2013) PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response. LEUKEMIA , 27 (3) pp. 650-660. 10.1038/leu.2012.285.

Shepherd, C; Banerjee, L; Cheung, CW; Mansour, MR; Jenkinson, S; Gale, RE; Khwaja, A; (2013) PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response. LEUKEMIA , 27 (3) pp. 650-660. 10.1038/leu.2012.285.

Shiltagh, N; Kirkpatrick, J; Cabrita, LD; Thalassinos, K; Tuddenham, GD; Hansen, DF; (2013) Solution structure and dynamics of the major FVIII binding region on von Willebrand factor: implications for type 2N von Willebrand disease. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 11 p. 13.

Simpson, TR; Li, F; Montalvo-Ortiz, W; Sepulveda, MA; Bergerhoff, K; Arce, F; Roddie, C; ... Quezada, SA; + view all (2013) Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. JOURNAL OF EXPERIMENTAL MEDICINE , 210 (9) pp. 1695-1710. 10.1084/jem.20130579.

Soulier, A; Blois, SM; Sivakumaran, S; Fallah-Arani, F; Henderson, S; Flutter, B; Rabbitt, EH; ... Chakraverty, R; + view all (2013) Cell-intrinsic regulation of murine dendritic cell function and survival by prereceptor amplification of glucocorticoid. BLOOD , 122 (19) pp. 3288-3297. 10.1182/blood-2013-03-489138.

Stengel, C; Jenner, E; Meja, K; Mayekar, S; Khwaja, A; (2013) Proliferation of PTEN-deficient haematopoietic tumour cells is not affected by isoform-selective inhibition of p110 PI3-kinase and requires blockade of all class 1 PI3K activity. BRITISH JOURNAL OF HAEMATOLOGY , 162 (2) pp. 285-289. 10.1111/bjh.12353.

Taher, AT; Porter, JB; Viprakasit, V; Kattamis, A; Chuncharunee, S; Sutcharitchan, P; Siritanaratkul, N; ... Cappellini, MD; + view all (2013) Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. AMERICAN JOURNAL OF HEMATOLOGY , 88 (6) pp. 503-506. 10.1002/ajh.23445.

Taher, AT; Porter, JB; Viprakasit, V; Kattamis, A; Chuncharunee, S; Sutcharitchan, P; Siritanaratkul, N; ... Cappellini, MD; + view all (2013) Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. American Journal of Hematology , 88 (6) pp. 503-506. 10.1002/ajh.23445.

Taher, AT; Porter, JB; Viprakasit, V; Kattamis, A; Chuncharunee, S; Sutcharitchan, P; Siritanaratkul, N; ... Cappellini, MD; + view all (2013) Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study. ANNALS OF HEMATOLOGY , 92 (11) pp. 1485-1493. 10.1007/s00277-013-1808-z.

Tannetta, DS; Dragovic, RA; Gardiner, C; Redman, CW; Sargent, IL; (2013) Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin. PLoS One , 8 (2) , Article e56754. 10.1371/journal.pone.0056754. Green open access
file

Thomas, AS; Mehta, AB; Hughes, DA; (2013) Diagnosing Gaucher disease: An on-going need for increased awareness amongst haematologists. BLOOD CELLS MOLECULES AND DISEASES , 50 (3) pp. 212-217. 10.1016/j.bcmd.2012.11.004.

Thomson, KJ; Kayani, I; Ardeshna, K; Morris, EC; Hough, R; Virchis, A; Goldstone, AH; ... Peggs, KS; + view all (2013) A response-adjusted PET-based transplantation strategy in primary resistant and relapsed Hodgkin Lymphoma. Leukemia , 27 (6) pp. 1419-1422. 10.1038/leu.2012.318.

Thomson, KJ; Peggs, KS; (2013) Allogeneic transplantation in the UK: an aggregation of marginal gains? BRITISH JOURNAL OF HAEMATOLOGY , 163 (2) pp. 149-159. 10.1111/bjh.12497.

Townsend, WM; Holroyd, A; Pearce, R; Mackinnon, S; Naik, P; Goldstone, AH; Linch, DC; ... Morris, EC; + view all (2013) Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning. Br J Haematol , 161 (4) 578 - 586. 10.1111/bjh.12294. Green open access
file

Townsend, WM; Holroyd, A; Pearce, R; Mackinnon, S; Naik, P; Goldstone, AH; Linch, DC; ... Morris, EC; + view all (2013) Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning. British Journal of Haematology , 161 (4) pp. 578-586. 10.1111/bjh.12294.

Tremblay, JP; Xiao, X; Aartsma-Rus, A; Barbas, C; Blau, HM; Bogdanove, AJ; Boycott, K; ... Gao, G; + view all (2013) Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Molecular Therapy , 21 (2) 266 - 268. 10.1038/mt.2013.4. Green open access
file

Truelove, E; Fielding, AK; Hunt, BJ; (2013) The coagulopathy and thrombotic risk associated with L-Asparaginase treatment in adults with acute lymphoblastic leukaemia. Leukemia , 27 (3) pp. 553-559. 10.1038/leu.2012.290.

Träger, U; Magnusson, A; Lahiri Swales, N; Wild, E; North, J; Lowdell, M; Björkqvist, M; (2013) JAK/STAT Signalling in Huntington's Disease Immune Cells. PLoS Curr , 5 10.1371/currents.hd.5791c897b5c3bebeed93b1d1da0c0648.

Underwood, M; Garagiola, I; Mackie, IJ; Machin, SJ; Metin, A; Gurgey, A; Peyvandi, F; (2013) In vitro characterisation of two ADAMTS13 mutants (I143T, Y570C) identified in two patients with congenital thrombotic thrombocytopenic purpura (TTP). JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 11 p. 491.

Viprakasit, V; Gattermann, N; Lee, JW; Porter, JB; Taher, AT; Habr, D; Martin, N; ... Cappellini, MD; + view all (2013) Geographical variations in current clinical practice on transfusions and iron chelation therapy across various transfusion-dependent anaemias. BLOOD TRANSFUSION , 11 (1) pp. 108-122. 10.2450/2012.0012-12.

Vora, A; Goulden, N; Wade, R; Mitchell, C; Hancock, J; Hough, R; Rowntree, C; (2013) Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. LANCET ONCOLOGY , 14 (3) pp. 199-209. 10.1016/S1470-2045(12)70600-9.

Wallis-Jones, S; McWhinnie, AJ; Madrigal, JA; Latham, K; Marsh, SGE; (2013) HLA-DRB1*03:49, a novel allele identified by group-specific sequence-based typing in a north European individual. TISSUE ANTIGENS , 82 (5) pp. 357-358. 10.1111/tan.12203.

Walter, P; Harmatz, P; Higa, A; Ng, V; Weyhmiller, M; Evans, P; Porter, J; ... Vichinsky, E; + view all (2013) INNATE IMMUNE CELL EXPRESSION OF PATTERN RECOGNITION RECEPTORS FROM TRANSFUSED THALASSEMIA MAJOR PATIENTS DURING INTENSIVE COMBINATION CHELATION THERAPY. AMERICAN JOURNAL OF HEMATOLOGY , 88 (5) E95-E95.

Walter, PB; Porter, J; Evans, P; Kwiatkowski, JL; Neufeld, EJ; Coates, T; Giardina, PJ; ... Harmatz, P; + view all (2013) Increased leucocyte apoptosis in transfused beta-thalassaemia patients. BRITISH JOURNAL OF HAEMATOLOGY , 160 (3) pp. 399-403. 10.1111/bjh.12076.

Walter, PB; Porter, J; Evans, P; Kwiatkowski, JL; Neufeld, EJ; Coates, T; Giardina, PJ; ... Harmatz, P; + view all (2013) Increased leucocyte apoptosis in transfused β-thalassaemia patients. British Journal of Haematology , 160 (3) pp. 399-403. 10.1111/bjh.12076.

Wang, ZJ; Wood, JC; Walter, PB; Schoennagel, BP; Evans, P; Neumayr, LD; Weyhmiller, MG; ... Fischer, R; + view all (2013) IRON DISTRIBUTION ASSESSED BY MRI IN SICKLE CELL DISEASE, THALASSEMIA AND DIAMOND BLACKFAN ANEMIA (MCSIO PILOT STUDY). AMERICAN JOURNAL OF HEMATOLOGY , 88 (5) E96-E96.

Warner, E; Birchall, M; Lowdell, MW; (2013) Tissue banking in ENT: challenges and methods. JOURNAL OF LARYNGOLOGY AND OTOLOGY , 127 (7) pp. 630-637. 10.1017/S0022215113001321.

Watts, MJ; Balsa, C; Pizzey, A; Ings, S; Antonio, A; (2013) THE RED CELL CONTENT OF APHERESIS PRODUCTS IS ROUTINELY OVERESTIMATED. CYTOTHERAPY , 15 (4) S25-S25. 10.1016/j.jcyt.2013.01.094.

Westwood, J-P; Webster, H; Mcguckin, S; Mcdonald, V; Machin, SJ; Scully, M; (2013) Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 11 (3) pp. 481-490. 10.1111/jth.12114.

Westwood, JP; Heelas, O; Langley, KM; Machin, SJ; Scully, M; (2013) Complement activation and cytokine response in TTP. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 11 pp. 61-62.

Westwood, JP; Langley, K; Heelas, E; Machin, SJ; Scully, M; (2013) Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura. British Journal of Haematology , 164 (6) 858- 866. 10.1111/bjh.12707. Green open access
file

Westwood, JP; Langley, K; Heelas, E; Machin, SJ; Scully, M; (2013) Role of complement in acute TTP. BRITISH JOURNAL OF HAEMATOLOGY , 161 p. 14.

Westwood, JP; Webster, H; Mc Guckin, S; McDonald, V; Machin, SJ; Scully, M; (2013) Benefit of early administration of rituximab in acute TTP and prophylactic use to prevent relapse. BRITISH JOURNAL OF HAEMATOLOGY , 161 p. 14.

Young-Gqamana, B; Brignol, N; Chang, H-H; Khanna, R; Soska, R; Fuller, M; Sitaraman, SA; ... Benjamin, ER; + view all (2013) Migalastat HCl Reduces Globotriaosylsphingosine (Lyso-Gb(3)) in Fabry Transgenic Mice and in the Plasma of Fabry Patients. PLOS ONE , 8 (3) , Article e57631. 10.1371/journal.pone.0057631. Green open access
file

Zimran, A; Pastores, GM; Tylki-Szymanska, A; Hughes, DA; Elstein, D; Mardach, R; Eng, C; ... Grabowski, GA; + view all (2013) Safety and efficacy of velaglucerase alfa in Gaucher disease type 1 patients previously treated with imiglucerase. AMERICAN JOURNAL OF HEMATOLOGY , 88 (3) pp. 172-178. 10.1002/ajh.23383.

Book

Cohen, H and O'Brien, P (Eds). (2013) Disorders of thrombosis and haemostasis in pregnancy: a guide to management. [Book]. Springer

Al-Rubeai, M; Naciri, M; (2013) Stem Cells and Cell Therapy. [Book]. Springer Verlag

Book chapter

Herrey, A; Cohen, H; Walker, F; (2013) Antithrombotic therapy for cardiac disorders in pregnancy. In: Cohen, H and O'Brien, P, (eds.) Disorders in thrombosis and haemostasis in pregnancy: a guide to management. Springer

Nieuwland, R; van der Pol, E; Gardiner, C; Sturk, A; (2013) Platelet-Derived Microparticles. In: Platelets. (pp. 453-467).

Proceedings paper

Alsubki, R; Field, A-C; Hirwarkar, P; Saudemont, A; Stauss, H; Morris, E; Thrasher, A; ... Qasim, W; + view all (2013) Engineering cord blood T cells for tumour immunotherapy. In: (Proceedings) Conference of the British-Society-for-Gene-and-Cell-Therapy (BSGCT). (pp. A20-A20). MARY ANN LIEBERT INC

Artim-Esen, B; Smoktunowicz, N; Pericleous, C; Ripoll, VM; Mackie, I; Chambers, R; Isenberg, DA; ... Giles, I; + view all (2013) Factor Xa Reactive Antibodies In Patients With Systemic LUPUS Erythematosus and Antiphospholipid Syndrome Have Differential Effects Upon Coagulation Assays and Endothelial CELLS. In: (Proceedings) 77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals. (pp. S9-S9). WILEY-BLACKWELL

Basner-Tschakarjan, E; Mingozzi, F; Chen, Y; Nathwani, A; Tuddenham, E; Riddell, A; Ng, C; ... High, KA; + view all (2013) Cellular Immune Responses To Vector In a Gene Therapy Trial For Hemophilia B Using An AAV8 Self-Complementary Factor IX Vector. In: (Proceedings) 55th Annual Meeting of the American-Society-of-Hematology. AMER SOC HEMATOLOGY

Beloki, L; Samuel, E; Ramirez, N; Olavarria, E; Lowdell, MW; (2013) Manufacturing of highly specific and functional T cells for adoptive immunotherapy from G-CSF-mobilised donors based on activation-dependent CD137 expression. In: (Proceedings) Annual Congress of the British-Society-for-Immunology. (pp. pp. 156-157). WILEY-BLACKWELL

Burnett, AK; Bowen, D; Russell, N; Knapper, S; Milligan, D; Hunter, AE; Khwaja, A; ... Hills, RK; + view all (2013) AC220 (Quizartinib) Can Be Safely Combined With Conventional Chemotherapy In Older Patients With Newly Diagnosed Acute Myeloid Leukaemia: Experience From The AML18 Pilot Trial. In: (Proceedings) 55th Annual Meeting of the American-Society-of-Hematology. AMER SOC HEMATOLOGY

Cappuzzo, V; Halliwell, JA; Ingrassia, F; Bavetta, R; Mistretta, S; Marcenu, R; Marsh, SGE; (2013) CHARACTERIZATION OF A NEW HLA-DRB1 ALLELE. In: (Proceedings) 27th Annual EFI European Immunogenetics and Histocompatibility Conference. (pp. p. 370). WILEY-BLACKWELL

Carpenter, BJM; Ghorashain, S; Nicholson, E; Griffin, J; Ahmadi, M; Zhang, L; Flutter, B; ... Chakraverty, R; + view all (2013) Over-expression of CXCR4 targets donor T-cells to tumour niches and enhances graft-versus-lymphoma. In: (Proceedings) 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT). (pp. S14-S14). NATURE PUBLISHING GROUP

Castleton, A; Dey, A; Patel, B; Beaton, B; Aucher, A; Davis, D; Fielding, A; (2013) Human Bone Marrow-Derived Mesenchymal Stromal Cells Permit Delivery, and Enhance Efficacy of Systemically Administered Oncolytic Measles Virotherapy to Disseminated Human Pre-B ALL Murine Xenograft Models in the Presence of Humoral Immunity. In: (Proceedings) 16th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT). (pp. S9-S9). NATURE PUBLISHING GROUP

Crawley, JTB; Efthymiou, M; Yu, Y; Watts, H; Noormohamed, H; Ma, D; Lane, DA; (2013) Protective effects of non-anticoagulant activated protein C variant (D36A/L38D/A39V) in a murine model of ischaemic stroke. In: (pp. p. 64). WILEY-BLACKWELL

Dey, A; Zhang, Y; Castleton, AZ; Patel, B; (2013) Improving the Oncolytic Activity of Measles Virus by Enhancing the Neutrophil-Mediated Response to Infected Tumor Cells. In: (Proceedings) 16th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT). (pp. S158-S158). NATURE PUBLISHING GROUP

Esen, BA; Pericleous, C; MacKie, I; Ioannou, Y; Rahman, A; Isenberg, DA; Giles, I; (2013) ANTI-FACTOR XA ANTIBODIES ARE SIGNIFICANTLY INCREASED IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME. In: (Proceedings) Annual Meeting of the British-Society-for-Rheumatology and British-Health-Professionals-in-Rheumatology. (pp. pp. 133-134). OXFORD UNIV PRESS

Fernandez-Vina, MA; Wang, T; Lee, SJ; Haagenson, M; Aljurf, M; Askar, M; Battiwalla, M; ... Setterholm, M; + view all (2013) MISMATCHES FOR HLA-C*03:03/03:04 MAY BE BETTER TOLERATED THAN OTHER MISMATCHES IN UNRELATED DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION. In: (Proceedings) 27th Annual EFI European Immunogenetics and Histocompatibility Conference. (pp. pp. 292-293). WILEY-BLACKWELL

Ferreira, YJ; Gardiner, C; Poli, M; Turner, K; Child, T; Sargent, IL; (2013) Human embryos release extracellular vesicles which may act as indicators of embryo quality. In: (pp. p. 104).

Fishman, JM; Lowdell, M; Ansari, T; Sibbons, P; De Coppi, P; Birchall, MA; (2013) Characterisation and immunogenicity of a decellularised skeletal muscle scaffold for laryngeal tissue engineering. In: (Proceedings) Spring Meeting for Clinician Scientists in Training. (pp. p. 42). ELSEVIER SCIENCE INC

Griffin, JE; Carpenter, B; Nicholson, E; Ghorashian, S; Holler, A; Velica, P; Sivakumaran, J; ... Chakraverty, R; + view all (2013) Generation of mycophenolate mofetil-resistant T-cells to enable adoptive immunotherapy during immunosuppressive treatment. In: (Proceedings) 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT). (pp. S72-S73). NATURE PUBLISHING GROUP

Halimeh, S; Sharief, LAT; Lawrie, AS; Kappert, G; Mackie, IJ; Peyvandi, F; Kadir, RA; (2013) Plasma FXIII LEVEL Variations During Menstrual CYCLE. In: (Proceedings) 55th Annual Meeting of the American-Society-of-Hematology. AMER SOC HEMATOLOGY

Laufer, J; Jathoul, A; Pule, M; Beard, P; (2013) Evaluation of genetically expressed absorbing proteins using photoacoustic spectroscopy. In: Oraevsky, AA and Wang, LV, (eds.) (Proceedings) Conference on Photons Plus Ultrasound - Imaging and Sensing. SPIE-INT SOC OPTICAL ENGINEERING

Lowdell, MW; Pearce, KF; Apperley, J; Dickinson, AM; Edinger, M; Greinix, H; Hauser, A; ... Hildebrandt, M; + view all (2013) The regulation of advanced therapy medicinal products in Europe and the role of academia. In: (Proceedings) 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT). (pp. S510-S510). NATURE PUBLISHING GROUP

Lown, RN; Latham, K; McWhinnie, AJ; Marsh, SGE; Madrigal, AJ; Shaw, BE; (2013) A MOVE FROM BLOOD TO ORAGENE SALIVA SELF-COLLECTION AT DONOR RECRUITMENT HAS HAD NO IMPACT ON DONOR RELIABILITY. In: (Proceedings) 27th Annual EFI European Immunogenetics and Histocompatibility Conference. (pp. pp. 304-305). WILEY-BLACKWELL

Mattar, C; Rosales, C; Fragata, R; Johana, N; Waddington, S; Biswas, A; Choolani, M; ... Chan, J; + view all (2013) Fetal Gene Therapy at Early and Late Gestation: Analysis of Outcomes and Postnatal Vector Challenge in a Macaque Model. In: (Proceedings) 16th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT). (pp. S222-S223). NATURE PUBLISHING GROUP

Munye, MM; Brown, RE; Tagalakis, AD; Barnes, JL; Ghatrora, RK; Pule, M; Lythgoe, MF; ... Hart, SL; + view all (2013) Minicircle Plasmids Result in Enhanced and Prolonged Transgene Expression of Airway Epithelial Cells Both In Vitro and In Vivo. In: (Proceedings) 16th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT). (pp. S167-S167). NATURE PUBLISHING GROUP

Nathwani, AC; Tuddenham, EGD; Reiss, UM; Recht, M; Shen, Y-M; Halka, KG; Basner-Tschakarjan, E; ... Davidoff, AM; + view all (2013) AAV-mediated gene transfer in patients with severe hemophilia B: Longer follow-up and expansion of the high dose cohort. In: (Proceedings) Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish-Society-for-Gene-and-Cell-Therapy. (pp. A25-A26). MARY ANN LIEBERT, INC

Oxenham, T; Southern, P; Briesemeister, D; Freeman, A; Peggs, K; Pankhurst, Q; Quezada, S; (2013) Development of Hyperthermia Treatments for Malignant Melanoma using Superparamagnetic Iron Oxide Nanoparticles in a Novel Transgenic In Vivo Model. In: (pp. p. 58). WILEY-BLACKWELL

Ricciardelli, I; Brewin, J; Blundell, M; Pule, M; Amrolia, P; (2013) Genetically Modified EBV-Specific Cytotoxic T Lymphocytes Induce Regression Of EBV Lymphoproliferation Despite Immunosuppression In Xenografted Mice: A Novel Strategy For EBV-Associated Post-Transplant Lymphoproliferative Disease. In: (Proceedings) 55th Annual Meeting of the American-Society-of-Hematology. AMER SOC HEMATOLOGY

Sabry, M; Lowdell, MW; (2013) The unique profile of tumour-primed natural killer cells shows loss of activating receptor expression and pro-inflammatory cytokine secretion upon activation. In: (Proceedings) Annual Congress of the British-Society-for-Immunology. (pp. p. 74). WILEY-BLACKWELL

Sanchez-Mazas, A; Buhler, S; Bekmane, U; Buus, S; Claas, FHJ; Dormoy, A; Dubois, V; ... Nunes, JM; + view all (2013) HLA-NET: A REAL EXAMPLE OF 'NETWORKING IN IMMUNOGENETICS'. In: (Proceedings) 27th Annual EFI European Immunogenetics and Histocompatibility Conference. (pp. pp. 300-301). WILEY-BLACKWELL

Schellekens, J; Shaw, BE; Mayor, NP; Cooke, L; Perry, J; Pearce, RM; Wilson, M; ... Marsh, SGE; + view all (2013) The influence of donor KIR repertoire on the clinical outcome after unrelated, T-cell depleted HSCT for patients with AML. In: (Proceedings) 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT). (pp. S41-S41). NATURE PUBLISHING GROUP

Thomson, KJ; Kayani, I; Ardeshna, K; Morris, EC; Hough, R; Virchis, A; Goldstone, AH; ... Peggs, KS; + view all (2013) A response-adjusted PET-based transplantation strategy in primary resistant and relapsed Hodgkin Lymphoma. In: (pp. pp. 1419-1422). NATURE PUBLISHING GROUP

Van der Pol, E; Gardiner, C; Harrison, P; Sturk, A; Van Leeuwen, TG; Nieuwland, R; (2013) Physical interpretation of the size and concentration of extracellular vesicles measured by advanced techniques. In: (pp. p. 22). WILEY-BLACKWELL

Weston-Davies, W; Westwood, J-P; Nunn, M; (2013) Phase 1 clinical trial of novel complement C5 inhibitor coversin. In: (Proceedings) 14th European Meeting on Complement in Human Disease. (pp. p. 264). PERGAMON-ELSEVIER SCIENCE LTD

Westwood, J-P; Langley, K; Heelas, E; Machin, S; Scully, M; (2013) Complement activation in thrombotic thrombocytopenic purpura. In: (Proceedings) 14th European Meeting on Complement in Human Disease. (pp. p. 273). PERGAMON-ELSEVIER SCIENCE LTD

Westwood, J-P; Mackay, A; Wedzicha, W; Machin, S; Scully, M; (2013) Complement anaphylatoxin levels during exacerbations of COPD and recovery. In: (Proceedings) 14th European Meeting on Complement in Human Disease. (pp. pp. 286-287). PERGAMON-ELSEVIER SCIENCE LTD

Wiener, E; Chennell, G; Garbowski, M; Porter, J; (2013) NON-TRANSFERRIN-BOUND IRON (NTBI) AND APOTRANSFERRIN STIMULATE THE EXPRESSION OF L-TYPE VOLTAGE-GATED CALCIUM CHANNELS OF CARDIOMYOCYTES. In: (Proceedings) BioIron 2013. (pp. E75-E75).

Conference item

Aitchison, K; Rahim, A; Reed, M; Hughes, D; Kinnon, C; Waddington, S; (2013) Developing lentiviral vectors for gene thrapy of type I Gaucher disease. Presented at: Conference of the British-Society-for-Gene-and-Cell-Therapy (BSGCT), Univ London, Royal Holloway, Egham, ENGLAND.

Aitchison, KL; Rahim, AA; Reed, M; Burke, DG; Hughes, DA; Heales, S; Kinnon, C; ... Howe, SJ; + view all (2013) Lentiviral vectors for gene therapy of type I Gaucher disease. Presented at: Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish-Society-for-Gene-and-Cell-Therapy, Madrid, SPAIN.

Hadjimichael, E; Thomas, A; Mehta, A; Hughes, D; (2013) Relationship of serum HIF1a, VEGF-A and TGF-a to clinical severity in Fabry disease. Presented at: 9th Annual World Symposium of the Lysosomal-Disease-Network (LDN), Orlando, FL.

Hendriksz, C; Burton, BK; Fleming, T; Giugliani, R; Harmatz, P; Hughes, D; Jones, S; ... Valayannopoulos, V; + view all (2013) A multi-national, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of BMN 110 treatment for mucopolysaccharidosis IVA (Morquio syndrome type A). Presented at: 9th Annual World Symposium of the Lysosomal-Disease-Network (LDN), Orlando, FL.

Rahim, AA; Sirka, E; Burke, DG; Buckley, SM; Cullen, E; Mukherji, S; Herbert, B; ... Waddington, SN; + view all (2013) In utero gene therapy rescue of an acute neonatal lethal mouse model of neuropathic Gaucher Disease. Presented at: Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish-Society-for-Gene-and-Cell-Therapy, Madrid, SPAIN.

Thomas, A; Mehta, A; Gomez, K; Hughes, D; (2013) Systematic screening detects no increase in incidence of lupus anticoagulant or heritable thrombophilias amongst patients with Fabry disease. Presented at: 9th Annual World Symposium of the Lysosomal-Disease-Network (LDN), Orlando, FL.

Thomas, AS; Mehta, AB; Hughes, DA; (2013) Thrombocytopenia and splenomegaly in pregnancy: a common presenting feature of Gaucher disease in females. Presented at: 53rd Annual Scientific Meeting of the British-Society-for-Haematology, Liverpool, ENGLAND.

Poster

Arrieta Bolanos, ER; Madrigal, JA; Shaw, B; (2013) Novel alleles of the Transforming Growth Factor β-1 promoter and exon 1. Presented at: 27th annual EFI European Immunogenetics and Histocompatibility Conference, Maastricht. Green open access
file

Arrieta Bolanos, ER; madrigal, J; marsh, S; shaw, B; Salazar-Sánchez, L; (2013) High resolution HLA-A, -B, -C and -DRB1 allele and haplotype frequencies in the Costa Rica Central Valley population. Presented at: 27th annual EFI European Immunogenetics and Histocompatibility Conference, Maastricht. Green open access
file

Thesis

Jeevaratnam, P; (2013) Early manifestations of Anderson Fabry disease. Doctoral thesis , UCL (University College London). Green open access
file

Notaridou, M; (2013) Functional analysis of low-moderate risk susceptibility genes emerging from pathway based approaches and genome wide association studies in epithelial ovarian cancer. Doctoral thesis , UCL (University College London). Green open access
file

Reyal, Y; (2013) The role of the polycomb group gene PCGF2 in human haematopoiesis. Doctoral thesis , UCL (University College London).

Samuel, ER; (2013) Novel approaches for the isolation and expansion of cytomegalovirus-specific T cells for adoptive immunotherapy. Doctoral thesis , UCL (University College London). Green open access
file

Shafi, NT; (2013) Pulmonary Involvement in Anderson Fabry Disease. Doctoral thesis , UCL (University College London). Green open access
file

Shiltagh, N; (2013) Solution structure of the factor VIII binding region on von Willebrand factor. Doctoral thesis , UCL (University College London). Green open access
file

This list was generated on Sun Jun 16 05:24:38 2019 BST.